Ex-Vivo Skin Explant Culture Is a Model for TSLP-Mediated Skin Barrier Immunity
暂无分享,去创建一个
[1] E. Wagner,et al. Psoriatic skin inflammation is promoted by c‐Jun/AP‐1‐dependent CCL2 and IL‐23 expression in dendritic cells , 2021, EMBO molecular medicine.
[2] S. Eberlin,et al. The Ex Vivo Skin Model as an Alternative Tool for the Efficacy and Safety Evaluation of Topical Products , 2020, Alternatives to laboratory animals : ATLA.
[3] T. Mohr,et al. Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy , 2019, Science Translational Medicine.
[4] S. Ziegler,et al. TSLP: from allergy to cancer , 2019, Nature Immunology.
[5] T. Bieber,et al. Atopic dermatitis , 2018, Nature Reviews Disease Primers.
[6] M. Fischbach,et al. Skin microbiota–host interactions , 2018, Nature.
[7] S. Sigismund,et al. Emerging functions of the EGFR in cancer , 2017, Molecular oncology.
[8] M. Hung,et al. JNK1 negatively controls anti-fungal innate immunity by suppressing CD23 expression , 2017, Nature Medicine.
[9] M. Baccarini,et al. Epidermal RAF prevents allergic skin disease , 2016, eLife.
[10] M. Holcmann,et al. Mechanisms underlying skin disorders induced by EGFR inhibitors , 2015, Molecular & cellular oncology.
[11] G. Lemke. Biology of the TAM receptors. , 2013, Cold Spring Harbor perspectives in biology.
[12] M. Pellegrino,et al. The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch , 2013, Cell.
[13] J. Fischer,et al. Epidermal EGFR Controls Cutaneous Host Defense and Prevents Inflammation , 2013, Science Translational Medicine.
[14] C. Berking,et al. MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study. , 2013, The Lancet. Oncology.
[15] G. Lemke,et al. Identification of Axl as a downstream effector of TGF-β1 during Langerhans cell differentiation and epidermal homeostasis , 2012, The Journal of experimental medicine.
[16] S. Molyneux,et al. Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis. , 2012, Immunity.
[17] Yong‐jun Liu,et al. Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen-presenting cells that induce proallergic T cells. , 2007, The Journal of allergy and clinical immunology.
[18] E. Wagner,et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins , 2005, Nature.
[19] S. Ziegler,et al. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin , 2005, The Journal of experimental medicine.
[20] G. Schuler,et al. Matrix Metalloproteinases 9 and 2 Are Necessary for the Migration of Langerhans Cells and Dermal Dendritic Cells from Human and Murine Skin1 , 2002, The Journal of Immunology.
[21] A. Giannetti,et al. Dysregulated activation of activator protein 1 in keratinocytes of atopic dermatitis patients with enhanced expression of granulocyte/macrophage-colony stimulating factor. , 2000, The Journal of investigative dermatology.
[22] B. Ryffel,et al. Migration of Langerhans cells and dermal dendritic cells in skin organ cultures: augmentation by TNF‐α and IL‐1 β , 1999, Journal of leukocyte biology.
[23] J. Smolle,et al. Entry into afferent lymphatics and maturation in situ of migrating murine cutaneous dendritic cells. , 1998, The Journal of investigative dermatology.